Ejection fraction assessment and survival: An analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

被引:38
作者
Gula, Lorne J. [1 ]
Klein, George J. [1 ]
Heltkamp, Anne S. [2 ]
Massel, David [1 ]
Krahn, Andrew D. [1 ]
Skanes, Allan C. [1 ]
Yee, Raymond [1 ]
Anderson, Jill [3 ]
Johnson, George W. [3 ]
Poole, Jeanne E. [4 ]
Mark, Daniel B. [2 ]
Lee, Kerry L. [2 ]
Bardy, Gust H. [3 ]
机构
[1] Univ Western Ontario, London, ON, Canada
[2] Duke Univ, Clin Res Inst, Durham, NC USA
[3] Seattle Inst Cardiac Res, Seattle, WA USA
[4] Univ Washington, Med Ctr, Seattle, WA 98195 USA
关键词
D O I
10.1016/j.ahj.2008.08.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Ejection fraction (EF) is an important method of mortality prediction among cardiac patients, and has been used to identify the highest risk patients for enrollment in the defibrillator primary prevention trials. Evidence suggests that measures of EF by different imaging modalities may not be equivalent. In the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial), the type of imaging modality for EF assessment was not mandated. Methods Baseline assessment of EF was performed using either echocardiography, radionuclide angiography (RNA), or contrast angiography. Multivariable analysis using a Cox proportional hazards model was used to examine whether the modality of assessing EF affected the likelihood of survival. Results Among the 2,521 patients enrolled in SCD-HeFT, EF was measured by RNA in 616 (24%), echocardiography in 1,469 (58%), and contrast angiography in 436 (17%). Mean EF as measured by RNA was 25.1 % +/- 6.9%; by echocardiography, 23.8 +/- 6.9%; and by angiography, 21.9 +/- 6.9%. These measures were significantly different (P <.001), and each pairwise comparison differed significantly (P <.001 for each). Multivariable analysis showed no significant difference in survival between patients enrolled based on RNA versus echocardiography (HR 1.06, 95% CI 0.88-1.28), RNA versus angiography (HR 1.25, 95% CI 0.97-1.62), or echocardiography versus angiography (HR 1.18, 95% CI 0.94-1.48). Conclusions Among patients enrolled in SCD-HeFT, the distribution of ejection fractions measured by radionuclide angiography differed from those measured by echocardiography or contrast angiograms. Survival did not differ according to modality of EF assessment. (Am Heart J 2008; 156:1196-200.)
引用
收藏
页码:1196 / 1200
页数:5
相关论文
共 16 条
[1]  
Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014
[2]  
Armstrong PW, 2004, CAN J CARDIOL, V20, P1075
[3]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[4]  
BARDY GH, 2000, SUDDEN CARDIAC DEATH, P323
[5]   Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance - Are they interchangeable? [J].
Bellenger, NG ;
Burgess, MI ;
Ray, SG ;
Lahiri, A ;
Coats, AJS ;
Cleland, JGF ;
Pennell, DJ .
EUROPEAN HEART JOURNAL, 2000, 21 (16) :1387-1396
[6]   Lack of agreement between left ventricular volumes and ejection fraction determined by two-dimensional echocardiography and contrast cineangiography in postinfarction patients [J].
Bernard, Y ;
Meneveau, N ;
Boucher, S ;
Magnin, D ;
Anguenot, T ;
Schiele, F ;
Vuillemenot, A ;
Bassand, JP .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2001, 18 (02) :113-122
[7]   A randomized study of the prevention of sudden death in patients with coronary artery disease [J].
Buxton, AE ;
Lee, KL ;
Fisher, JD ;
Josephson, ME ;
Prystowsky, EN ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1882-1890
[8]  
Centers for Medicare & Medicaid Services,, PUB 100 03 MED NAT C
[9]   Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction [J].
Hohnloser, SH ;
Kuck, KH ;
Dorian, P ;
Roberts, RS ;
Hampton, JR ;
Hatala, R ;
Fain, E ;
Gent, M ;
Connolly, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2481-2488
[10]   Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia [J].
Moss, AJ ;
Hall, WJ ;
Cannom, DS ;
Daubert, JP ;
Higgins, SL ;
Klein, H ;
Levine, JH ;
Saksena, S ;
Waldo, AL ;
Wilber, D ;
Brown, MW ;
Heo, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1933-1940